One-month Clinical Evaluation of Silicone Hydrogel Definitive 65 HPT Contact Lenses
1 other identifier
interventional
35
1 country
2
Brief Summary
Comparison of different contact lens materials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2014
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2014
CompletedFirst Submitted
Initial submission to the registry
November 28, 2014
CompletedFirst Posted
Study publicly available on registry
December 9, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 23, 2015
CompletedAugust 12, 2020
August 1, 2020
7 months
November 28, 2014
August 10, 2020
Conditions
Outcome Measures
Primary Outcomes (4)
questionnaire addressing subjective comfort and wear time
Subjects rated on a scale from 1 to 10, where 1 was 'poor' and 10 was 'excellent'.
subjects will be followed-up for one month
limbal redness - ocular biomicroscopy
Assessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.
subjects will be followed-up for one month
conjunctival redness - ocular biomicroscopy
Assessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.
subjects will be followed-up for one month
corneal staining - ocular biomicroscopy
Assessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.
subjects will be followed-up for one month
Study Arms (2)
Definitive 65 HPT
EXPERIMENTALThe Test product were the Definitive 65 (Filcon V4) lenses with Hydra PEG surface coating. This material is produced by Contamac Ltd. and the contact lenses were manufactured by Appenzeller Kontaktlinsen AG.
Definitive 65
ACTIVE COMPARATORThe Control product was the commercially available Definitive 65 (Efrofilcon A) lens. This material is produced by Contamac Ltd. and the contact lenses were manufactured by Appenzeller Kontaktlinsen AG.
Interventions
Eligibility Criteria
You may qualify if:
- willing and able to sign informed consent form
- ages 18 years or older
- Subjects must have owned spectacles or contact lenses prior to enrolment for this trial
- Spherical power between -10.00 D and +10.00 D (at vertex distance 0 mm)
- Astigmatic power ≤0.75 D
You may not qualify if:
- Eye injury or surgery within 3 months immediately prior to enrolment for this trial
- Pre-existing ocular irritation that would preclude contact lens fitting
- Currently enrolled in an ophthalmic clinical trial
- Evidence of systemic or ocular abnormality, infection or disease which is likely to affect successful wear of contact lenses or use of the accessory solutions, as determined by the investigator
- Any use of medications for which contact lens wear could be contradicted, as determined by the investigator
- Current extended-wear users (sleep-in overnight)
- Current monovision lens wearers
- Pregnant women and nursing mothers
- Best-corrected visual acuity worse than 6/9 (LogMAR: +0.20; Snellen decimal: 0.63)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Contamac Ltdlead
- Hartwig Research Centercollaborator
Study Sites (2)
Siehste
Kassel, Germany
Kresinky
Würzburg, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreas Hartwig, PhD, FAAO
Hartwig Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2014
First Posted
December 9, 2014
Study Start
November 8, 2014
Primary Completion
May 23, 2015
Study Completion
May 23, 2015
Last Updated
August 12, 2020
Record last verified: 2020-08